Lab to Impact: Medical Device Commercialization – A Journey from Breakthrough Research to Patient-Ready Technology

Join the Center for Technology Licensing for a virtual session focused on medical device innovation and regulation.  

Bringing groundbreaking medical devices from concept to patient care is no small feat. It requires a careful balance of scientific ingenuity, strategic development, and regulatory compliance. Join us for an exclusive panel discussion featuring top experts who have successfully navigated this complex landscape.  

This session will provide invaluable insights into the journey from idea to market-ready medical technology, covering key aspects such as: 

• Navigating the FDA approval process 

• Balancing innovation with regulatory requirements 

• Strategies for successful device development 

• Emerging challenges in the medical device industry  

Whether you’re considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices. 

Meet the expert panelists: 

• Mark Melkerson – Former FDA Deputy Director, Office of Health Technology / CDRH / ODE; Principal, MNM Consulting 

• Thomas Roueche – President & CEO, Fesarius Therapeutics 

• Jason Spector, MD – Chief, Division of Plastic & Reconstructive Surgery, Weill Cornell Medicine; Co-Founder, Fesarius Therapeutics 

Register for the event.